Mark Sulkowski
Senior Associate Dean for Clinical Trials, Professor of Medicine, Johns Hopkins University · University of California (San Diego) Medical Center
Credentials: · · · ·
History
PresentProfessor of Medicine · University of California (San Diego) Medical Center

1995–1997- 1992–1995
Internal Medicine
- 1988–1992
Research
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Nature · 2009 · 2,916 citations
Boceprevir for untreated chronic HCV genotype 1 infection
New England Journal of Medicine · 2011 · 2,030 citations
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection
New England Journal of Medicine · 2014 · 1,119 citations

42 papers · 1 as a fellow
- JM
40 papers

35 papers

31 papers

29 papers

29 papers

29 papers

27 papers
Grants
- 2020–2030
HIV MASLD Clinical Research Network (HCRN)
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $8.7M · Indiana University Indianapolis
- 2012–2024
Midcareer Investigator Award in Patient-Oriented Research (Parent K24)
National Institute on Drug Abuse · K24
Contact PI · $1.2M · Johns Hopkins University
- 2021–2022
Hep Dart 2021: Frontiers in Drug Development for Hepatology
National Institute of Allergy and Infectious Diseases · R13
PI · $12K · Emory University
- 2003–2021
HCV Disease Management in HIV-HCV Coinfected IDUs
National Institute on Drug Abuse · R01
Contact PI · $8M · Johns Hopkins University
Clinical trials
- 2021
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Principal investigator · Completed
Johns Hopkins University
- 2020–2021
Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection
Principal investigator · Terminated · Phase 2
Johns Hopkins University
- 2017–2019
Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence
Principal investigator · Unknown
Proteus Digital Health, Inc.
- 2017–2020
deLIVER: Direct Acting Antiviral Effects on the Liver
Principal investigator · Completed · Phase 4
Johns Hopkins University

